APA (7th ed.) Citation

Cogo, A., Mangin, G., Maïer, B., Callebert, J., Mazighi, M., Chabriat, H., . . . Kubis, N. (2021). Increased serum QUIN/KYNA is a reliable biomarker of post-stroke cognitive decline. Molecular Neurodegeneration, 16(1), 1. https://doi.org/10.1186/s13024-020-00421-4

Chicago Style (17th ed.) Citation

Cogo, Adrien, Gabrielle Mangin, Benjamin Maïer, Jacques Callebert, Mikael Mazighi, Hughes Chabriat, Jean-Marie Launay, Gilles Huberfeld, and Nathalie Kubis. "Increased Serum QUIN/KYNA Is a Reliable Biomarker of Post-stroke Cognitive Decline." Molecular Neurodegeneration 16, no. 1 (2021): 1. https://doi.org/10.1186/s13024-020-00421-4.

MLA (9th ed.) Citation

Cogo, Adrien, et al. "Increased Serum QUIN/KYNA Is a Reliable Biomarker of Post-stroke Cognitive Decline." Molecular Neurodegeneration, vol. 16, no. 1, 2021, p. 1, https://doi.org/10.1186/s13024-020-00421-4.